Investigational device for patients with non-valvular afib

Trial ID:
Matthew J Price, M.D.
This trial is evaluating the safety and effectiveness of the Amulet device compare to NOAC (non-vitamin K antagonist oral anticoagulants) therapy in patients with non-valvular atrial fibrillation (Afib) at increased risk for ischemic stroke and who are recommended for long tern NOAC therapy.
* Be at high risk of stroke or systemic embolism, defined as a CHA2DS2-VASc score of = 3<br>* Be eligible for long-term NOAC therapy<br>* Be 18 years of age or older<br>* Meet all other eligibility criteria

Contact Info:

  • Clinical Research Services